Quoin shareholders approve NED compensation increase to $250k base retainer

Quoin Pharmaceuticals, Ltd.

Annual base retainer for non-employee directors increased to up to $250,000, set annually by Compensation Committee.
Range for annual option awards raised to no less than $20,000 and no more than $200,000, at Compensation Committee discretion.
All 7 director nominees re-elected; say-on-pay approved with 18,127,445 for votes.
Shareholders approved 401(k) matching contribution changes and ratified CBIZ CPAs P.C. as auditor.
Record date July 15, 2026: 70,294,615 ordinary shares outstanding; voting results include 16.3M broker non-votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.